diclofenac has been researched along with thyroxine in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Arsequell, G; Blasi, D; Bosch, L; Centeno, NB; Cotrina, EY; Pinto, M; Planas, A; Quintana, J; Valencia, G; Vilà, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aoyama, A; Demura, H; Demura, R; Koike, S; Kusakabe, K; Natori, Y; Yamaguti, N | 1 |
| Benvenga, S; Cahnmann, HJ; Gregg, RE; Robbins, J | 1 |
| Benvenga, S; Li Calzi, L; Robbins, J | 1 |
| Crook, PR; Fowler, PD; Hothersall, TE | 1 |
| Hazelton, RA; Ratcliffe, JG; Ratcliffe, WA; Thomson, JA | 1 |
| Benvenga, S; Cahnmann, HJ; Robbins, J | 1 |
| Albrecher, B; Eber, O; Langsteger, W; Sternad, H | 1 |
| Arai, S; Hama, Y; Kondo, T; Mineshita, M; Warabi, H; Yasuda, H | 1 |
| Buchinger, W; Nadler, K; Pongratz, R; Rainer, F; Semlitsch, G | 1 |
| Karami-Tehrani, F; Mokarram, P; Salami, S | 1 |
| Almeida, MR; Alves, I; Arsequell, G; Cardoso, I; Macedo, B; Planas, A; Saraiva, MJ; Valencia, G | 1 |
| Kamimori, H; Kinouchi, H; Kitagawa, H; Matsuyama, K | 1 |
2 review(s) available for diclofenac and thyroxine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pseudogout attack associated with chronic thyroiditis and Sjögren's syndrome.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chondrocalcinosis; Colchicine; Diclofenac; Female; Follow-Up Studies; Gout Suppressants; Humans; Recurrence; Sjogren's Syndrome; Thyroiditis, Autoimmune; Thyroxine | 1999 |
1 trial(s) available for diclofenac and thyroxine
| Article | Year |
|---|---|
Diclofenac sodium and thyroid function tests.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Diclofenac; Female; Humans; Male; Middle Aged; Osteoarthritis; Phenylacetates; Random Allocation; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 1982 |
15 other study(ies) available for diclofenac and thyroxine
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenation.
Topics: Diflunisal; Flufenamic Acid; Halogenation; Humans; Kinetics; Ligands; Models, Molecular; Prealbumin; Protein Multimerization; Protein Structure, Secondary; Structure-Activity Relationship | 2013 |
[The effects of diclofenac sodium on thyroid function tests in vivo and in vitro].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Protein Binding; Radioimmunoassay; Thyroid Function Tests; Thyroxine; Triiodothyronine | 1990 |
Characterization of the binding of thyroxine to high density lipoproteins and apolipoproteins A-I.
Topics: Apolipoprotein A-I; Apolipoproteins A; Autoradiography; Binding Sites; Diclofenac; Furosemide; Lipoproteins, HDL; Lipoproteins, VLDL; Mefenamic Acid; Temperature; Thyroid Hormones; Thyroxine; Thyroxine-Binding Proteins; Time Factors | 1989 |
Effect of free fatty acids and nonlipid inhibitors of thyroid hormone binding in the immunoradiometric assay of thyroxin-binding globulin.
Topics: Binding, Competitive; Diclofenac; False Negative Reactions; Fatty Acids, Nonesterified; Furosemide; Humans; Mefenamic Acid; Phenylacetates; Radioimmunoassay; Reagent Kits, Diagnostic; Thyroxine; Thyroxine-Binding Proteins | 1987 |
The effect of fenclofenac on thyroid function tests in vivo and in vitro.
Topics: Adult; Aged; Arthritis; Diagnostic Errors; Diclofenac; Female; Humans; Male; Middle Aged; Phenylacetates; Thyroid Function Tests; Thyroxine; Triiodothyronine | 1980 |
Characterization of thyroid hormone binding to apolipoprotein-E: localization of the binding site in the exon 3-coded domain.
Topics: Affinity Labels; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Apolipoproteins E; Binding Sites; Blood Proteins; Diclofenac; Exons; Furosemide; Isoelectric Focusing; Mefenamic Acid; Mice; Molecular Sequence Data; Mutation; Photochemistry; Thyroxine | 1993 |
[Modification of maximal binding capacity and radio-T3/T4 distribution by carbamazepine and diclofenac].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbamazepine; Diclofenac; Female; Humans; Male; Middle Aged; Prealbumin; Reference Values; Serum Albumin; Thyrotropin; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine | 1993 |
[Effect of aceclofenac on thyroid hormone binding and thyroid function].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Male; Thyroglobulin; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 2000 |
Competition of tamoxifen with thyroxine for TBG binding: ligand binding assay and computational data.
Topics: Binding, Competitive; Diclofenac; Furosemide; Humans; Mefenamic Acid; Models, Molecular; Molecular Conformation; Tamoxifen; Thyroxine; Thyroxine-Binding Proteins | 2001 |
Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.
Topics: Amyloid Neuropathies; Diclofenac; Diflunisal; Flufenamic Acid; Humans; Iodine; Iodobenzoates; Molecular Structure; Prealbumin; Protein Binding; Thyroxine | 2004 |
Surface plasmon resonance assay of inhibition by pharmaceuticals for thyroxine hormone binging to transport proteins.
Topics: Binding, Competitive; Diclofenac; Inhibitory Concentration 50; Pharmaceutical Preparations; Prealbumin; Protein Binding; Surface Plasmon Resonance; Thyroxine; Thyroxine-Binding Globulin | 2016 |